Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2013 R21 RFA-CA-12-002 PAN, TINGRUI UNIVERSITY OF CALIFORNIA AT DAVIS DIGITAL ONE-DISC-ONE-COMPOUND ARRAY FOR HIGH-THROUGHPUT DISCOVERY OF CANCER-TARGE Complete
2016 R33 RFA-CA-15-003 GARRAWAY, LEVI A BROAD INSTITUTE, INC. CLINICAL IMPLEMENTATION OF SINGLE CELL TUMOR TRANSCRIPTOME ANALYSIS Complete
2019 R21 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Complete
2000 R21 PAR-99-102 PALLAVICINI, MARIA G. UNIVERSITY OF CALIFORNIA SAN FRANCISCO PROTEIN SIGNATURES OF LEUKEMIC CELLS Complete
2002 R33 PAR-99-100 ISSA, JEAN-PIERRE J UNIVERSITY OF TEXAS MD ANDERSON CAN CTR NEOPLASIA AND METHYLATED CPG ISLANDS AMPLIFICATION Complete
2005 R33 RFA-CA-05-003 D'ERRICO, FRANCESCO YALE UNIVERSITY CHEMOTHERAPY WITH INJECTABLE MICRODROPLETS Complete
2008 R33 RFA-CA-07-036 VIDAL, MARC DANA-FARBER CANCER INST APPLICATION OF TECHNOLOGIES FOR INTERACTOME NETWORK ANALYSES OF CANCER MUTATIONS Complete
2011 R33 RFA-CA-10-004 JU, JINGFANG STATE UNIVERSITY NEW YORK STONY BROOK IDENTIFICATION OF POST-TRANSCRIPTIONALLY REGULATED TARGETS BY TRIP-CHIP/SEQ Complete
2015 R33 RFA-CA-14-004 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN-MADISON SCALABLE CANCER GENOMICS VIA NANOCODING AND SEQUENCING Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2002 R21 PAR-01-104 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) PROTEIN LOCALIZATION: MULTI-APERTURE NEAR-FIELD OPTICS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Complete
1999 R21 PAR-98-067 BRADLEY, ALLAN BAYLOR COLLEGE OF MEDICINE DEVELOPMENT OF BAC ARRAY COMPARITIVE GENOMIC HYBRIDIZATI Complete
2001 R33 PAR-99-100 HUNTER, IAN W MASSACHUSETTS INSTITUTE OF TECHNOLOGY ANDROGEN RECEPTOR BIOCHIPS--PROSTATE CANCER MANAGEMENT Complete
2003 R44 PAR-01-105 NEDELKOV, DOBRIN INTRINSIC BIOPROBES, INC. AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS Complete
2007 R21 RFA-CA-07-003 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROFLUIDIC CHANNELS FOR HIGH DENSITY, HIGH PERFORMANCE CULTURE ASSAYS Complete
2010 R21 RFA-CA-09-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER METHODS FOR THE ANALYSIS OF TUMOR EXTRACELLULAR MATRIX Complete
2014 R21 RFA-CA-13-001 TEMPST, PAUL SLOAN-KETTERING INST CAN RESEARCH IMMOBILIZED PROTEASE ACTIVITY TESTS FOR DEVELOPING FUNCTIONAL CANCER BIOMARKERS. Complete
2017 R21 RFA-CA-16-001 DAVIS, RONALD WAYNE STANFORD UNIVERSITY Nanoneedle microrobots for single cancer cell manipulation and genome editing Complete
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Complete
2000 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2002 R44 PAR-01-105 DREES, BETH E ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2006 R33 RFA-CA-06-002 KNOWLES, DAVID W. UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB NOVEL IMAGE-BASED SCREENING OF MAMMARY TUMORS Complete
2009 R21 RFA-CA-08-006 MESSMER, DAVORKA UNIVERSITY OF CALIFORNIA SAN DIEGO REAL TIME QUANTITATIVE MULTIPLEX ANALYSIS OF CELL-CELL INTERACTIONS Complete
2013 R21 RFA-CA-12-002 ONG, SHAO-EN UNIVERSITY OF WASHINGTON KINASE PROFILING WITH QUANTITITATIVE CHEMOPROTEOMICS Complete
2016 R33 RFA-CA-15-003 NAGRATH, SUNITHA UNIVERSITY OF MICHIGAN HIGH THROUGHPUT GO CHIP ISOLATION OF LUNG CTCS FOR MOLECULAR DIAGNOSIS AND DRUG TESTING Complete
2019 R33 RFA-CA-18-005 LEI, YUGUO UNIVERSITY OF NEBRASKA LINCOLN A Single Conical Tube Device for Precision CAR-T Cells Manufacturing Complete
2000 R21 PAR-99-102 DABORA, SANDRA L BRIGHAM AND WOMEN'S HOSPITAL MUTANT ANALYSIS OF TSC1 & TSC2 IN TSC RELATED DISORDERS Complete
2002 R33 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2005 R33 RFA-CA-05-004 CHAURAND, PIERRE VANDERBILT UNIVERSITY PREPARATION OF CANCER TISSUES FOR MS IMAGING OF PROTEINS Complete
2008 R33 RFA-CA-07-036 BOGDANOV, ALEXEI A UNIV OF MASSACHUSETTS MED SCH WORCESTER TRANSCRIPTION FACTOR REPORTER TECHNOLOGY Complete
2011 R33 RFA-CA-10-004 TANG, KEQI BATTELLE PACIFIC NORTHWEST LABORATORIES VALIDATION AND ADVANCED DEVELOPMENT OF EMERGING TECHNOLOGIES Complete
2015 R33 RFA-CA-14-004 YEAKLEY, JOANNE MULLIGAN BIOSPYDER TECHNOLOGIES, INC. RASL-SEQ EXPRESSION PROFILING OF FFPE TISSUES Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2002 R21 PAR-01-104 VIDAL, MARC DANA-FARBER CANCER INSTITUTE A C. ELEGANS LOCALIZATION-OF-EXPRESSION MAPPING PROJECT Complete
2005 R21 RFA-CA-05-002 POOLE, LESLIE B WAKE FOREST UNIVERSITY HEALTH SCIENCES PROFILING OF REDOX-SENSITIVE SIGNALING PROTEINS Complete
2008 R21 RFA-CA-07-033 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY NANOBIOSENSING METHOD FOR POINT MUTATION DETECTION OF CANCER Complete
2011 R21 RFA-CA-10-001 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL ENHANCED FORMALIN FIXATION TO IMPROVE TESTS ON SOLID TISSUES Complete
2015 R21 RFA-CA-14-003 IAFRATE, ANTHONY JOHN MASSACHUSETTS GENERAL HOSPITAL HIGHLY MULTIPLEXED FISH FOR IN SITU GENOMICS Complete
2018 R21 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Complete
2015 R21 RFA-CA-14-003 DRAKE, RICHARD R. MEDICAL UNIVERSITY OF SOUTH CAROLINA DIRECT TUMOR GLYCAN PROFILING ON TISSUE MICROARRAYS Complete
2018 R21 RFA-CA-17-010 ENGLER, ADAM JEFFREY UNIVERSITY OF CALIFORNIA, SAN DIEGO Developing Adhesome Technology as a Physical Marker of Highly Metastatic Cells Complete
1999 R21 PAR-98-067 SINGER, ROBERT H YESHIVA UNIVERSITY FISH AND CHIPS--SINGLE CELL EXPRESSION OF CANCER GENES Complete
2001 R33 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete

Pages